It’s no surprise that the majority of the scientists receiving money from third party payers, I.e., Big Pharma, we’re cancer researchers. Those payments were not to compensate the cancer research scientists for discovering cures for the many types of cancer. Instead, the payments were bribes to keep the scientists from revealing that they discovered cures for cancer, which would eventually put Big Pharma out of business. The disclosures would at least reveal certain cures that would negate the astronomically expensive anti-cancer drugs.
Comment: this shows that taxpayer funded research is patented by public employees who then receive royalty payments.
“We estimate that up to $350 million in royalties from third parties were paid to NIH scientists during the fiscal years between 2010 and 2020,” Open the Books CEO Adam Andrzejewski told reporters in a telephone news conference on May 9.
“We draw that conclusion because, in the first five years, there has been $134 million that we have been able to quantify of top-line numbers that flowed from third-party payers, meaning pharmaceutical companies or other payers, to NIH scientists.”
It’s no surprise that the majority of the scientists receiving money from third party payers, I.e., Big Pharma, we’re cancer researchers. Those payments were not to compensate the cancer research scientists for discovering cures for the many types of cancer. Instead, the payments were bribes to keep the scientists from revealing that they discovered cures for cancer, which would eventually put Big Pharma out of business. The disclosures would at least reveal certain cures that would negate the astronomically expensive anti-cancer drugs.
Comment: this shows that taxpayer funded research is patented by public employees who then receive royalty payments.